InnovationRx is a weekly digest of healthcare news that covers the latest developments and innovations in the field. This week, a significant event has occurred in the United States, as a patient has been hospitalized with a severe case of avian flu. The individual contracted the virus from sick and dead birds in a flock on his property. The strain of the virus is similar to those found in poultry in the US and a recent case in British Columbia. California has declared a state of emergency due to the spread of H5N1, which has affected over 640 dairies in the state. The federal government has stockpiled H5N1 vaccines, and Moderna is developing a bird flu vaccine that is currently in clinical trials.
On a positive note, there have been no documented cases of avian flu spreading from person to person. The FDA has approved remestemcel-L-rknd for the treatment of pediatric patients with graft-versus-host disease, and SiteOne Therapeutics has raised $100 million for the development of non-opioid painkillers. Additionally, a successful pig kidney transplant has been performed, marking a significant milestone in organ transplantation.
In other healthcare news, the FDA is considering banning Red No. 3, a food coloring linked to health issues, and a suspect has been indicted for the murder of UnitedHealthcare CEO Brian Thompson. Dengue virus infections are on the rise, and legislation in Congress may impact pharmacy benefit managers.
In the world of startups, Gameto, a next-generation IVF company, facilitated the birth of a baby using their product, Fertilo, for the first time. Holoclara is entering phase 1 clinical trials for a drug derived from worm secretions, and Verge Genomics is developing a new obesity management pill. BioAge Labs has entered a research partnership with Novartis, and Precision Neuroscience has raised $102 million for their brain implant technology.
Overall, the healthcare industry continues to see advancements and breakthroughs that have the potential to improve patient outcomes and quality of life. Stay tuned for more updates in the next edition of InnovationRx.
